FR2162045A1 - 8-pyrimidylaminomethyl-ergoline derivs - with adrenolytic activity - Google Patents

8-pyrimidylaminomethyl-ergoline derivs - with adrenolytic activity

Info

Publication number
FR2162045A1
FR2162045A1 FR7242381A FR7242381A FR2162045A1 FR 2162045 A1 FR2162045 A1 FR 2162045A1 FR 7242381 A FR7242381 A FR 7242381A FR 7242381 A FR7242381 A FR 7242381A FR 2162045 A1 FR2162045 A1 FR 2162045A1
Authority
FR
France
Prior art keywords
pyrimidylaminomethyl
ergoline
derivs
dihydrolysergamine
cpd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7242381A
Other languages
French (fr)
Other versions
FR2162045B1 (en
Inventor
Giuliana Arcari
Luigi Bernardi
Maurizio Foglio
Alfredo Glaesser
Aldemio Temperilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of FR2162045A1 publication Critical patent/FR2162045A1/en
Application granted granted Critical
Publication of FR2162045B1 publication Critical patent/FR2162045B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Title derivs. of formula (I) (where R is H or CH3 R1 and R2 are H, 1-3C alkyl or phenyl, and R3 is H, halogen, CH3, C2H5, OCH3, OC2H5 phenyl, NO2, (acyl)amino CN or carboxamido) which are long-acting adrenolytics with low toxicity, are prepd. by reacting dihydrolysergamine or 1-methyl-dihydrolysergamine with a cpd. which is capable of converting the amino gp. into a guanidino gp. reacting the resulting 6-methyl-or 1,6-dimethyl-8 beta-guanidinomethyl-10 alpha-ergoline with a beta-dicarbonyl cpd. of the formula R1-CO-CHR3-CO-R2 at 10-150 degrees C for 1 hr. to 6 days; and isolating and pyrifying the resulting (I).
FR7242381A 1971-12-02 1972-11-29 8-pyrimidylaminomethyl-ergoline derivs - with adrenolytic activity Granted FR2162045A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3193271 1971-12-02

Publications (2)

Publication Number Publication Date
FR2162045A1 true FR2162045A1 (en) 1973-07-13
FR2162045B1 FR2162045B1 (en) 1976-06-11

Family

ID=11234509

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7242381A Granted FR2162045A1 (en) 1971-12-02 1972-11-29 8-pyrimidylaminomethyl-ergoline derivs - with adrenolytic activity

Country Status (20)

Country Link
JP (1) JPS5634597B2 (en)
AT (1) AT321478B (en)
AU (1) AU465155B2 (en)
BE (1) BE792188A (en)
CA (1) CA975773A (en)
CH (1) CH590276A5 (en)
CS (1) CS173612B2 (en)
DE (1) DE2259012C3 (en)
DK (1) DK138689B (en)
ES (1) ES409189A1 (en)
FR (1) FR2162045A1 (en)
GB (1) GB1357238A (en)
HU (1) HU165530B (en)
IE (1) IE37429B1 (en)
IL (1) IL40944A (en)
NL (1) NL153197B (en)
NO (1) NO136643C (en)
SE (1) SE385301B (en)
SU (1) SU617014A3 (en)
ZA (1) ZA728459B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7416120A (en) * 1973-12-21 1975-06-24 Farmaceutici Italia PROCESS FOR PREPARING PYRIMIDINOAMINOMETHYLERGOLINE DERIVATIVES.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
AU465155B2 (en) 1975-09-18
DK138689C (en) 1979-03-19
NL153197B (en) 1977-05-16
JPS4862800A (en) 1973-09-01
DK138689B (en) 1978-10-16
HU165530B (en) 1974-09-28
IL40944A (en) 1976-04-30
CH590276A5 (en) 1977-07-29
DE2259012A1 (en) 1973-06-07
JPS5634597B2 (en) 1981-08-11
IL40944A0 (en) 1973-01-30
ES409189A1 (en) 1976-01-01
CA975773A (en) 1975-10-07
AT321478B (en) 1975-04-10
SU617014A3 (en) 1978-07-25
BE792188A (en) 1973-06-01
IE37429L (en) 1973-06-02
DE2259012C3 (en) 1978-09-21
AU4935172A (en) 1974-05-30
NO136643C (en) 1977-10-12
DE2259012B2 (en) 1978-02-09
FR2162045B1 (en) 1976-06-11
NL7215817A (en) 1973-06-05
IE37429B1 (en) 1977-07-20
ZA728459B (en) 1973-09-26
CS173612B2 (en) 1977-02-28
SE385301B (en) 1976-06-21
NO136643B (en) 1977-07-04
GB1357238A (en) 1974-06-19

Similar Documents

Publication Publication Date Title
DE3464132D1 (en) NAPHTHOQUINONE DERIVATIVES
ES389890A1 (en) 3-acylamino-4-phenylquinolines carrying a substituent on the benzene ring
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
FR2162045A1 (en) 8-pyrimidylaminomethyl-ergoline derivs - with adrenolytic activity
ES422386A1 (en) O-ethyl-S-n-propyl-0-2-cyanovinyl-thionothiol-phosphoric acid esters
GB1208698A (en) Coumarins
FR2217328A1 (en) Herbicidal anilides - N-alpha-haloacyl-N-(O-and/or S-contg heterocyclyl-(m)ethyl) -2-alkyl-aniline derivs
GB1213439A (en) Pesticides comprising thiosemicarbazides
SE7609586L (en) N-ALKYLDIPHENYLAMINES
GB1420533A (en) Pyridine derivatives having juvenile hormone activity
FR2255895A1 (en) Substd. benzo(b,d)pyrans - as anxiolytic, antidepressive and antipsychotic agents
GB1337506A (en) Oxobenzofuran carboxamide anti-inflammatory agents
ES422827A1 (en) Benzoylphenylguanidines
ES400453A1 (en) N-acyl-(piperazinoalkyl)-pyrazoles
GB1459949A (en) Penicillin compounds their production and their medicinal use
FR2097038A1 (en) 1-(substd phenyl)-2-oxo-4-piperazinocarbonyl pyrrolidines - analgesic
FR2152374A1 (en) Ellipticin and analogues - by an industrial scale process
GB1424938A (en) Process for the production of bis-halogen carbonyl anilines
FR2148056A1 (en) Thiazole-2,4-dimethanol dicarbamates - with circulator and cns activity
ES451217A1 (en) 1-Methyl-3-formyl-3-substituted ureas
GB1511475A (en) Hydrazinopyridazine derivatives having antihypertensive activity
FR2245659A1 (en) 2-Hydroxy-5-thia-1-azabicyclo (4,2,0)octan-8-ones - with bacteriostatic activity, prepd. from azetidin-2-ones
GB1428187A (en) 6-aminopenicillanic acid derivatives and process for the preparation of the same
GB1435276A (en) Oxazolidines and conversion to propanolamines
IE38387B1 (en) Phenylguanidine derivatives their production and their medicinal use

Legal Events

Date Code Title Description
ST Notification of lapse